| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $15.46B | +0.1% |
| Cost of Revenue | $6.50B | -4.5% |
| Gross Profit | $8.96B | +3.7% |
| R&D Expense | $408.0M | +2.3% |
| SG&A Expense | $6.33B | +3.1% |
| Operating Income | $1.84B | -26.7% |
| Interest Expense | $431.0M | +72.4% |
| Pre-tax Income | $1.42B | -35.4% |
| Income Tax | $385.0M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.07B | -22.6% |
| Accounts Receivable | $2.17B | +4.4% |
| Inventory | $1.59B | -14.0% |
| Current Assets | $5.53B | -10.0% |
| Total Assets | $25.60B | -8.1% |
| Current Liabilities | $5.74B | +4.7% |
| Total Liabilities | $15.93B | -4.2% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.77B | -44.2% |
| Capital Expenditures | $434.0M | -7.5% |
| Investing Cash Flow | -$425.0M | +12.9% |
| Financing Cash Flow | -$1.56B | +38.1% |
| Free Cash Flow | $1.33B | -50.5% |
| -26.8% |
| Net Income | $1.03B | -38.1% |
| EPS (Basic) | $0.54 | -40.0% |
| EPS (Diluted) | $0.54 | -40.0% |
| Stockholders' Equity |
| $9.67B |
| -13.8% |